Martin Wilson, General Counsel at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 587 shares at $6.45 ($4K) on 2025-05-20, disclosed to the SEC on 2025-05-22.
Open-market sale of $4k RCKT by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2026-08-17 | $12K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $2K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $12K | — | Filing → |